NLC India’s first coal-based supercritical thermal power plant coming up in Kanpur - IN PICS
时间:2024-06-26 12:46:35 阅读(143)
To meet the rising power demand in India, the NLC India Limited (formerly Neyveli Lignite Corporation Limited) will begin the operation of its first super-critical coal-based thermal power plant soon.2/8
The NLC India Limited’s first coal-based supercritical power plant – Neyveli Uttar Pradesh Power Ltd (NUPPL) is being built at Uttar Pradesh’s Ghatampur Tehsil.
The NUPPL power plant project received the GOI sanction on July 27, 2016. This is being built in a joint venture with Uttar Pradesh Rajya Vidyut Utpadan Nigam Ltd (UPRVUNL).
4/8The NUPPL super critical thermal power project is being built in an area of 1013.97 hectares. Of these, the power plant area is 768 hectares and the area for township projects is 68 hectares.
5/8The project is being built at an estimated cost of Rs 19406.12 crore. Of this, the total capital expenditure (capex) till June 02, 2023 is Rs 15109.6 crore.
6/8The total capacity of the NUPPL thermal power plant is 1980 MW. A total of three units are there (3*660 MW).
7/8The NUPPL has built a rail siding of 43.2 km long for carrying the coal from Hamirpur railway station to its plant.
8/8The NUPPL thermal power project has boosted the local economy. About 1000 contractual manpower have been sourced from Project Affected People (PAPs).
猜你喜欢
- Asia’s favorite bonds to lure more investors amid rate cut bets
- Bulls Return- Strong growth, FII trend, pause in rate hikes point at long sustainable bull run in coming months
- Buy Dixon, Wipro shares for gains; Bank Nifty may head to 38000 soon
- Balaji Solutions files draft papers with Sebi to raise funds via IPO
- Nifty support at 18300, resistance seen at 18400-18500; key levels to watch out for in coming sessions
- Nifty outlook negative, may fall below 18300 if 18459 support breached; sell these two stocks in near-term
- Bank Nifty failing to break through 42,000; inflation, Adani saga, FIIs weigh heavy on index
- AstraZeneca India launches innovative drug for HER-2 positive metastatic breast cancer patients in India
- Nifty sits near crucial support levels, will bulls return today- 5 things to know before opening bell